It should be easier for GPs to work out the cheapest drug options


The issue

THE continuing removal of medicines from the Pharmaceutical Benefits Scheme (PBS), concurrent with increasing patient co-payments for those medicines that remain on the PBS, makes it cheaper per dose for some patients to buy their medicines on a private prescription.

This is especially true if they buy larger quantities than the PBS will allow. 

Limitations on the quantities of some Schedule 2 and 3 medicines sold over the counter mean that, for some products, it is cheaper per dose for